Med Chem - Alzheimers Flashcards

1
Q

what is the leading cause of dementia

A

alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the 2 main pathologic hallmarks of alzheimers

A

amyloid plaques (abnormal clusters of B-amyloid protein)

appearance of neurofibrillary tangles (made of tau protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

in alzheimer’s disease, there is ____ overactivation and ___ deficit

A

NMDA receptor overactivation

acetylcholine deficit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

in AD, the neurofibrillary tangles accumulate interneuronally or intraneuronally

A

intra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

in AD, the B-amyloid protein plaques accumulate within the neuron or out of the neuron

A

out of the neuron - extraneuronally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

true or false

in AD, AB production outweighs AB clearance

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

*what are the 2 fates of the amyloid precursor protein

name the enzymes involved**

A

either forms plaques or doesnt

if doesnt form a plaque - was cut by a-secretase (ADAM 10)

if DOES form a plaque, is cut by B-secretase/BACE-1. once cut, y-secretase cuts as well in the middle of the membrane.

this forms an AB monomer. the precision by Y-secretese determines the length of this monomer. it is normally between 38-43 aa. 42aa has a HIGH TENDENCY TO FORM PLAQUES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

explain how intracellular neurofibrillary tangles made of tau protein are formed in alzheimers disease

A

normally, tau protein is attached to microtubule inside the cell. this tau protein can either be phosphorylated or dephosphorylated

in AD, there is upregulation of kinases and downregulation of phosphatases. thus, the tau protein gets hyperphosphorylated and these taus aggregate and form a tangle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

true or false

current therapies for AD focus on addressing the pathological causes (AB plaques and tau protein tangles)

A

FALSE - no therapies for that yet

therapies now just are focused on enhancing memory function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

true or false

in AD, there is too much acetylcholine

A

FALSE - too little

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

excess glutamate can lead to….

A

cell death

primarily mediated by NMDA receptor - BAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the 3 neurotransmittors most commonly affected by AD

A

serotonin
NE
acetycholine (most)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 classes of drugs for AD that exist at the moment

A

ACHE inhibitors
nicotinic acetycholine receptor agonists
NMDA receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

in AD, acetylcholine levels are low.

this is possibly due to a decrease in what 2 things

A

decrease in:

-choline transporters
-choline acetyltransferases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the major/minor pathway for ach synthesis

A

major - from recycled choline

minor - from serine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the biosynthetic precursor of acetylcholine

17
Q

what is the precursor of serotonin

18
Q

what is the precursor of GABA

19
Q

*the catalytic triad of the esteratic site of ache is formed by what 3 amino acids

A

serine, histidine, and glutamate

20
Q

*in the hydrolysis of acetylcholine by acetylcholine esterase, which amino acid gets acetylated and thus only choline is left behind

A

serine-200

21
Q

explain how ACHE I work in alzheimers patients

A

prevent the breakdown of acetycholine, brain chemical believed to be important for memory and thinking

22
Q

name 2 REVERSIBLE AchE inhibitors for AD

A

donepezil
galantamine

23
Q

name a pseudoirreversible ACHE inhibitor

A

rivastigmine – has a carbamate

24
Q

memantine MOA and how it’s helpful in AD patients

A

NMDA receptor antagonist

protects against the destructive effects of too much glutamate

25
Q

true or false

the basic Nitrogen of donepezil must be at position 4

26
Q

true or false

donepezil is peripherally acting

A

FALSE - central acting

needs to be centrally acting to be used for AD

27
Q

true or false

donepezil is a reversible, competitive inhibitor of ACHE

A

false

reversible, noncompetitive

28
Q

true or false

donepezil has similar selectivity for ACHE vs BUTECH

A

false – lot more selective for ACHE, and also more selective for ACHE in the brain rather than in the periphry

29
Q

dual MOA of galantamine

A

ACHE inhibitor

acts at an allosteric nicotonic site to increase cholinergic action (nACHR agonism!)

30
Q

memantine blocks glutamate-induced excitotoxicity

it does this by binding where exactly?

A

close to the magnesium binding site within the NMDA ion channel

31
Q

true or false

memantine is a noncompetitive inhibitor

32
Q

true or false

memantine binds with high affinity

A

FALSE - low affinity

this is good tho bc it has a better AE profile